| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |